Abiopharma

ATI INC (ATI) Reports the reporting period Financial Results ATI INC (ATI) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: (2)
• Net Income: 1.00
• EPS: $1.00
• Cash and equivalents: $221 million
  • anticipated by management from strategic investments and the integration of acquired 4businesses; (d) volatility in the price and availability of the raw materials that are critical to the manufacture of our products; (e) declines in the value of our defined benefit pension plan assets or unfavorable changes in laws or regulations that govern pension plan funding; (f) labor disputes or work stoppages; (g) equipment outages; (h) business and economic disruptions associated with extraordinary events beyond our control, such as war, terrorism, international conflicts, public health issues, such as epidemics or pandemics, natural disasters and climate-related events that may arise in the future and (i) other risk factors summarized in our Annual Report on Form 10-K for the year ended December 28, 2025